company background image
MXC

MGC Pharmaceuticals ASX:MXC Stock Report

Last Price

AU$0.012

Market Cap

AU$35.0m

7D

-4.0%

1Y

-70.7%

Updated

05 Dec, 2022

Data

Company Financials +
MXC fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance0/6
Financial Health4/6
Dividends0/6

MXC Stock Overview

MGC Pharmaceuticals Limited, a bio-pharma company, develops and supplies phytomedicines in worldwide.

MGC Pharmaceuticals Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for MGC Pharmaceuticals
Historical stock prices
Current Share PriceAU$0.012
52 Week HighAU$0.05
52 Week LowAU$0.012
Beta1.58
1 Month Change-11.11%
3 Month Change-25.00%
1 Year Change-70.73%
3 Year Change-63.64%
5 Year Change-84.00%
Change since IPO-91.72%

Recent News & Updates

Recent updates

MGC Pharmaceuticals (ASX:MXC) Has Debt But No Earnings; Should You Worry?

Jun 23
MGC Pharmaceuticals (ASX:MXC) Has Debt But No Earnings; Should You Worry?

MGC Pharmaceuticals (ASX:MXC) Has Debt But No Earnings; Should You Worry?

Mar 09
MGC Pharmaceuticals (ASX:MXC) Has Debt But No Earnings; Should You Worry?

Auditors Have Doubts About MGC Pharmaceuticals (ASX:MXC)

Oct 08
Auditors Have Doubts About MGC Pharmaceuticals (ASX:MXC)

If You Had Bought MGC Pharmaceuticals (ASX:MXC) Shares A Year Ago You'd Have Earned 346% Returns

Feb 21
If You Had Bought MGC Pharmaceuticals (ASX:MXC) Shares A Year Ago You'd Have Earned 346% Returns

What Does MGC Pharmaceuticals' (ASX:MXC) CEO Pay Reveal?

Dec 30
What Does MGC Pharmaceuticals' (ASX:MXC) CEO Pay Reveal?

Shareholder Returns

MXCAU PharmaceuticalsAU Market
7D-4.0%-6.1%1.0%
1Y-70.7%-26.2%-2.2%

Return vs Industry: MXC underperformed the Australian Pharmaceuticals industry which returned -23.7% over the past year.

Return vs Market: MXC underperformed the Australian Market which returned -1.8% over the past year.

Price Volatility

Is MXC's price volatile compared to industry and market?
MXC volatility
MXC Average Weekly Movement10.9%
Pharmaceuticals Industry Average Movement10.2%
Market Average Movement8.9%
10% most volatile stocks in AU Market15.9%
10% least volatile stocks in AU Market4.1%

Stable Share Price: MXC is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 11% a week.

Volatility Over Time: MXC's weekly volatility (11%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2014n/aRoby Zomerhttps://mgcpharma.com.au

MGC Pharmaceuticals Limited, a bio-pharma company, develops and supplies phytomedicines in worldwide. The company produces and supplies medicinal cannabis products; and non-cannabis phytomedicines. Its principal product candidates include CimetrA, which is in phase III clinical trial for the symptomatic treatment of early COVID-19; CannEpil, a phase IIb cannabis-based therapy for drug-resistant Epilepsy; and CogniCann that is in phase II clinical trial for the symptomatic relief of Dementia.

MGC Pharmaceuticals Limited Fundamentals Summary

How do MGC Pharmaceuticals's earnings and revenue compare to its market cap?
MXC fundamental statistics
Market CapAU$34.99m
Earnings (TTM)-AU$20.35m
Revenue (TTM)AU$4.73m

7.4x

P/S Ratio

-1.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
MXC income statement (TTM)
RevenueAU$4.73m
Cost of RevenueAU$4.17m
Gross ProfitAU$562.87k
Other ExpensesAU$20.91m
Earnings-AU$20.35m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.007
Gross Margin11.89%
Net Profit Margin-430.00%
Debt/Equity Ratio40.5%

How did MXC perform over the long term?

See historical performance and comparison